Back to search

Article

A CRISPR-based ultrasensitive assay redefines “undetectable” SARS-CoV-2 antibodies in kidney transplant recipients after COVID-19 vaccination

2022-01-27

Abstract excerpt

<title>Abstract</title> <p>An ultrasensitive assay for the detection of antibodies to SARS-CoV-2 is critically needed for evaluating the adaptive humoral immune response and infection rates in immunocompromised subpopulations. Here, we report an Ultrasensitive CRISPR-based Antibody Detection (UCAD) assay that translates the detection of serum antibodies against the receptor binding domain (RBD) of SARS-CoV-2 spik...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0b66f9c5-1641-50e3-a740-0ed9939ea2a3
DOI
10.21203/rs.3.rs-1278355/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A CRISPR-based ultrasensitive assay redefines “undetectable” SARS-CoV-2 antibodies in kidney transplant recipients after COVID-19 vaccinationDOI 10.21203/rs.3.rs-1278355/v1
Select a neighboring publication to make it the new centre.